创新医疗
(002173)
| 流通市值：69.57亿 | | | 总市值：72.94亿 |
| 流通股本：4.21亿 | | | 总股本：4.41亿 |
| 利润表 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 营业总收入 | 512,473,983.32 | 337,763,261.5 | 166,663,239.83 | 781,251,044.68 |
| 营业总成本 | 597,203,125.52 | 394,716,441.55 | 192,751,923.47 | 852,868,865.07 |
| 其他经营收益 | | | | |
| 营业利润 | -84,022,240.13 | -53,403,868 | -26,078,176.47 | -30,568,962.67 |
| 利润总额 | -84,731,208.35 | -54,469,329 | -26,487,642.44 | -28,884,669.63 |
| 净利润 | -84,121,779.06 | -54,698,244.55 | -26,352,838.72 | -36,255,305.06 |
| 每股收益 | | | | |
| 其他综合收益 | - | - | - | - |
| 综合收益总额 | -84,121,779.06 | -54,698,244.55 | -26,352,838.72 | -36,255,305.06 |
| 资产负债表 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 流动资产: | | | | |
| 流动资产合计 | 530,675,144.65 | 563,959,576.6 | 519,344,693.26 | 544,315,867.04 |
| 非流动资产: | | | | |
| 非流动资产合计 | 1,463,572,508.76 | 1,485,577,135.52 | 1,615,732,451.92 | 1,634,800,807.43 |
| 资产总计 | 1,994,247,653.41 | 2,049,536,712.12 | 2,135,077,145.18 | 2,179,116,674.47 |
| 流动负债: | | | | |
| 流动负债合计 | 283,773,202.65 | 304,476,883.57 | 280,793,841.33 | 296,218,922.31 |
| 非流动负债: | | | | |
| 非流动负债合计 | 81,099,478.44 | 82,608,518.98 | 116,217,511.43 | 118,479,121.02 |
| 负债合计 | 364,872,681.09 | 387,085,402.55 | 397,011,352.76 | 414,698,043.33 |
| 所有者权益(或股东权益): | | | | |
| 归属于母公司股东权益合计 | 1,618,584,838.88 | 1,650,704,535.38 | 1,724,741,909.67 | 1,749,891,597.45 |
| 股东权益合计 | 1,629,374,972.32 | 1,662,451,309.57 | 1,738,065,792.42 | 1,764,418,631.14 |
| 负债和股东权益合计 | 1,994,247,653.41 | 2,049,536,712.12 | 2,135,077,145.18 | 2,179,116,674.47 |
| 现金流量表 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 经营活动产生的现金流量: | | | | |
| 经营活动现金流入小计 | 534,296,431.47 | 374,429,719.59 | 186,576,265.53 | 850,867,367.09 |
| 经营活动现金流出小计 | 548,494,243.62 | 376,915,741.38 | 190,078,064.19 | 774,937,205.58 |
| 经营活动产生的现金流量净额 | -14,197,812.15 | -2,486,021.79 | -3,501,798.66 | 75,930,161.51 |
| 投资活动产生的现金流量: | | | | |
| 投资活动现金流入小计 | 186,579,381.68 | 186,540,147.36 | - | 208,133,182.77 |
| 投资活动现金流出小计 | 176,915,810.15 | 145,999,230.81 | 11,517,920.17 | 205,685,761.66 |
| 投资活动产生的现金流量净额 | 9,663,571.53 | 40,540,916.55 | -11,517,920.17 | 2,447,421.11 |
| 筹资活动产生的现金流量: | | | | |
| 筹资活动现金流入小计 | 45,082,500 | 45,000,000 | 15,044,447.22 | 23,006,676.09 |
| 筹资活动现金流出小计 | 98,108,945.52 | 68,516,272.35 | 13,087,596.02 | 32,096,317.94 |
| 筹资活动产生的现金流量净额 | -53,026,445.52 | -23,516,272.35 | 1,956,851.2 | -9,089,641.85 |
| 汇率变动对现金及现金等价物的影响 | - | - | - | - |
| 现金及现金等价物净增加额 | -57,560,686.14 | 14,538,622.41 | -13,062,867.63 | 69,287,940.77 |
| 期末现金及现金等价物余额 | 129,230,688.07 | 201,329,996.62 | 173,728,506.58 | 186,791,374.21 |
| 补充资料: | | | | |
| 现金及现金等价物的净增加额 | - | 14,538,622.41 | - | 69,287,940.77 |